Center for Regulatory Effectiveness: A Senator’s Unilateral Recommendation To Ban Menthol is Inconsistent with the Recommendations of the FDA

Center for Regulatory Effectiveness: A Senator’s Unilateral Recommendation To Ban Menthol is Inconsistent with the Recommendations of the FDA

April 25th, 2011 // 12:37 pm @

WASHINGTON, April 25, 2011 /PRNewswire/ — Senator Blumenthal states that his recommendation to ban menthol cigarettes is based on the report of the FDA Tobacco Product Scientific Advisory Committee. Unfortunately he must have not read the report in its entirety. The TPSAC made it clear that no action can be taken on a ban until the issue of contraband has been addressed.

See the article entitled TPSAC Concludes: “Should FDA choose to implement a ban…FDA would need to assess the potential for contraband menthol cigarettes as required by the Act” at http://www.thecre.com/tpsac/?p=1282

Center for Regulatory Effectiveness (CRE) has informed TPSAC that China exports 400 billion cigarettes per year. CRE continues to issue reports based on information obtained from Chinese government publications which demonstrate that the contraband industry in China is flourishing and will be even more prosperous with a menthol ban. CRE presentations to TPSAC clearly demonstrated that a menthol ban will not only result in an increase in adult and underage smoking of tobacco products but in doing so both groups will be exposed to heavy metals at a level which is an order of magnitude greater than legal cigarettes.

Consequently, if the Congress is going to get involved in the FDA review of the TPSAC report they should do so only after they have read the entire record.

SOURCE Center for Regulatory Effectiveness
Back to top

RELATED LINKS
http://www.thecre.com


Subscribe Now

Featured Partner